arrow
M

Mark A. Dawson

University of Melbourne
H指数:55
被引数:1.8万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

The stress-sensing MARCH5 axis governs blood cancer apoptotic resilience via tractable protein–protein interactions

压力感应的MARCH5轴通过可调节的蛋白质-蛋白质相互作用调控血液癌症的凋亡抗性

Blood
IF23.1
2026-09-110
PRE
Rb-driven transcription limits its tumour-suppressive effects in breast cancer

Rb驱动的转录限制其在乳腺癌中的肿瘤抑制作用

Nature
IF48.5
2026-08-120
OA
Mosaic chromosomal alterations are suppressed in older adults with HIV

HIV感染者老年人中嵌合染色体异常受到抑制

2026-07-210
OAAI
SUMOylation enhances DNMT1 function to repress mega-intergenic RNAs and viral mimicry
2026-07-210
PRE
Antigen reactivity defines tissue-resident memory and exhausted T cells in tumors

抗原反应性定义了肿瘤中的组织驻留记忆T细胞和耗竭T细胞。

2025-12-290
OAAI
Acute Resistance to BET Inhibitors Remodels Compensatory Transcriptional Programs Via p300 Co-Activation

急性对BET抑制剂的耐药性通过p300协同激活重塑补偿性转录程序

BLOOD
IF23.1
2024-11-050
PRE
CRISPR-Cas9 screening identifies an IRF1-SOCS1-mediated negative feedback loop that limits CXCL9 expression and antitumor immunity (vol 42, 113014, 2023)
2024-02-010
OA
Discovery of a highly potent, selective, orally bioavailable inhibitor of KAT6A/B histone acetyltransferases with efficacy against KAT6A-high ER+ breast cancer

发现一种高效,选择性,口服生物利用度的KAT6A/B组蛋白乙酰转移酶抑制剂,对KAT6A-high ER乳腺癌有效

2023-10-0121
OAAI
Inhibition of METTL3 Results in a Cell-Intrinsic Interferon Response That Enhances Antitumor Immunity

抑制METTL3导致细胞内在的干扰素反应,从而增强抗肿瘤免疫力

2023-08-0729
PRE
CRISPR-Cas9 screening identifies an IRF1-SOCS1-mediated negative feedback loop that limits CXCL9 expression and antitumor immunity

CRISPR-Cas9筛选确定了限制CXCL9表达和抗肿瘤免疫的IRF1-SOCS1-mediated负反馈回路

2023-08-016
OA